| Citation: | Branch of Organ Transplantation of Chinese Medical Association. Technical specification for diagnosis and treatment of drug-resistant bacterial infection after organ transplantation (2019 edition)[J]. ORGAN TRANSPLANTATION, 2019, 10(4): 352-358. doi: 10.3969/j.issn.1674-7445.2019.04.002
|
| [1] |
HU FP, GUO Y, ZHU DM, et al. Resistance trends among clinical isolates in China reported from CHINET surveillance of bacterial resistance, 2005-2014[J]. Clin Microbiol Infect, 2016, 22 (Suppl 1): S9-S14. DOI: 10.1016/j.cmi.2016.01.001.
|
| [2] |
SEN A, CALLISEN H, LIBRICZ S, et al. Complications of solid organ transplantation: cardiovascular, neurologic, renal, and gastrointestinal[J]. Crit Care Clin, 2019, 35(1):169-186. DOI: 10.1016/j.ccc.2018.08.011.
|
| [3] |
GARNACHO-MONTERO J, AMAYA-VILLAR R. Multiresistant acinetobacter baumannii infections: epidemiologyand management[J]. Curr Opin Infect Dis, 2010, 23(4):332-339. DOI: 10.1097/QCO.0b013e32833ae38b.
|
| [4] |
杨富, 陈兰, 方芳, 等.肝移植术后多重耐药菌感染危险因素的系统评价[J].上海交通大学学报(医学版), 2015, 35(7):1015-1022.DOI: 11.3969/j.issn.1674-8115.2015.07.016.
YANG F, CHEN L, FANG F, et al. Systematic evaluation of risk factors of multi-drug resistant organisms infection after liver transplantation[J]. J Shanghai Jiaotong Univ (Med Sci), 2015, 35(7):1015-1022. DOI: 11.3969/j.issn.1674-8115.2015.07.016.
|
| [5] |
QIN X, YANG Y, HU F, et al. Hospital clonal dissemination of Enterobacter aerogenes producing carbapenemase KPC-2in a Chinese teaching hospital[J]. J Med Microbiol, 2014, 63(Pt 2):222-228. DOI: 10.1099/jmm.0.064865-0.
|
| [6] |
李智斌, 张更, 刘克普, 等.公民逝世后器官捐献肾移植早期多重耐药菌感染的临床研究[J].器官移植, 2017, 8(5):386-391.DOI: 10.3969/j.issn.1674-7445.2017.05.010.
LI ZB, ZHANG G, LIU KP, et al. Clinical study of early infection of multi-drug resistant organisms after renal transplantation from organ donation after citizen's death[J]. Organ Transplant, 2017, 8(5):386-391. DOI: 10.3969/j.issn.1674-7445.2017.05.010.
|
| [7] |
GALVÃO LM, OLIVEIRA APR, IBANÊS AS, et al. Fatal case of donor-derived colistin-resistant carbapenemase-producing Klebsiella pneumoniae transmission in cardiac transplantation[J]. Braz J Infect Dis, 2018, 22(3):235-238. DOI: 10.1016/j.bjid.2018.04.005.
|
| [8] |
Clinical and Laboratory Standards Institute. Performance standards for antimicrobial susceptibility testing[M]. 27th ed. Wayle: Clinical and Laboratory Standards Institute, 2017.
|
| [9] |
胡付品, 郭燕, 朱德妹, 等. 2017年CHINET中国细菌耐药性监测[J].中国感染与化疗杂志, 2018, 18(3):241-251. DOI: 10.16718/j.1009-7708.2018.03.001.
HU FP, GUO Y, ZHU DM, et al. CHINET surveillance of bacterial resistance across China: report of the results in 2017[J]. Chin J Infect Chemoth, 2018, 18(3):241-251. DOI: 10.16718/j.1009-7708.2018.03.001.
|
| [10] |
高建, 张媛, 成伟丽, 等.器官捐献移植肾动脉细菌感染破裂的诊疗对策[J].器官移植, 2017, 8(4):311-313, 332. DOI: 10.3969/j.issn.1674-7445.2017.04.012.
GAO J, ZHANG Y, CHENG WL, et al. Diagnosis and treatment on renal artery rupture of transplant kidney caused by bacterial infection after organ donation[J]. Organ Transplant, 2017, 8(4):311-313, 332. DOI: 10.3969/j.issn.1674-7445.2017.04.012.
|
| [11] |
胡付品, 郭燕, 朱德妹, 等. 2016年中国CHINET细菌耐药性监测[J].中国感染与化疗杂志, 2017, 17(5):481-491. DOI: 10.16718/j.1009-7708.2017.05.001.
HU FP, GUO Y, ZHU DM, et al. CHINET surveillance of bacterial resistance across China: report of the results in 2016[J]. Chin J Infect Chemoth, 2017, 17(5):481-491. DOI: 10.16718/j.1009-7708.2017.05.001.
|
| [12] |
ZHANG R, LIU L, ZHOU H, et al. Nationwide surveillance of clinical carbapenem-resistant enterobacteriaceae (CRE) strains in China[J]. EBioMedicine, 2017, 19:98-106. DOI: 10.1016/j.ebiom.2017.04.032.
|
| [13] |
VAROTTI G, DODI F, TERULLA A, et al. Impact of carbapenem-resistant Klebsiella pneumoniae (CR-KP) infections in kidney transplantation[J]. Transpl Infect Dis, 2017, 19(6). DOI: 10.1111/tid.12757.
|
| [14] |
SIMKINS J, MUGGIA V, COHEN HW, et al. Carbapenem-resistant Klebsiella pneumoniae infections in kidney transplant recipients: a case-control study[J]. Transpl Infect Dis, 2014, 16(5):775-782. DOI: 10.1111/tid.12276.
|
| [15] |
BURCKHARDT I, LAST K, ZIMMERMANN S. Shorter incubation times for detecting multi-drug resistant bacteria in patient samples: defining early imaging time points using growth kinetics and total laboratory automation[J]. Ann Lab Med, 2019, 39(1):43-49. DOI: 10.3343/alm.2019.39.1.43.
|
| [16] |
王明贵.广泛耐药革兰阴性菌感染的实验诊断、抗菌治疗及医院感染控制:中国专家共识[J].中国感染与化疗杂志, 2017, 17(1):82-93. DOI: 10.16718/j.1009-7708.2017.01.015.
WANG MG. Laboratory diagnosis, clinical management and infection control of the infections caused by extensively drug-resistant Gram-negative bacilli: a Chinese consensus statement[J]. Chin J Infect Chemoth, 2017, 17(1):82-93. DOI: 10.16718/j.1009-7708.2017.01.015.
|
| [17] |
POUCH SM, KUBIN CJ, SATLIN MJ, et al. Epidemiology and outcomes of carbapenem-resistant Klebsiella pneumoniae bacteriuria in kidney transplant recipients[J]. Transpl Infect Dis, 2015, 17(6):800-809. DOI: 10.1111/tid.12450.
|
| [18] |
BIAS TE, MALAT GE, LEE DH, et al. Clinical outcomes associated with carbapenem resistant Klebsiella pneumoniae (CRKP) in abdominal solid organ transplant (SOT) recipients[J]. Infect Dis (Lond), 2018, 50(1):67-70. DOI: 10.1080/23744235.2017.1354259.
|
| [19] |
KENGKLA K, KONGPAKWATTANA K, SAOKAEW S, et al. Comparative efficacy and safety of treatment options for MDR and XDR acinetobacter baumannii infections: a systematic review and network Meta-analysis[J]. J Antimicrob Chemother, 2018, 73(1):22-32. DOI: 10.1093/jac/dkx368.
|
| [20] |
SCHWABER MJ, CARMELI Y. An ongoing national intervention to contain the spread of carbapenem-resistant enterobacteriaceae[J]. Clin Infect Dis, 2014, 58(5):697-703. DOI: 10.1093/cid/cit795.
|
| [21] |
LAGACÉ-WIENS P, WALKTY A, KARLOWSKY JA. Ceftazidime-avibactam: an evidence-based review of its pharmacology and potential use in the treatment of Gram-negative bacterial infections[J]. Core Evid, 2014, 9:13-25. DOI: 10.2147/CE.S40698.
|
Figures(8)
WeChat Subscription Account
Wechat Service Account
Supported by:
Beijing Renhe Information Technology Co. Ltd
DownLoad:
